Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) Q2 2024 Earnings

ABEO·Reported August 12, 2024·Before market open

Diluted EPS came in at $-0.75, missed the $-0.33 consensus by $0.42.

Diluted EPS
$-0.75missed by $0.42
Consensus: $-0.33
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q2 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Abeona Therapeutics Inc.'s Q2 2024 earnings report.

Abeona Therapeutics Inc. (ABEO) reported Q2 2024 earnings on August 12, 2024 before market open.

Abeona Therapeutics Inc. reported diluted EPS of $-0.75 for Q2 2024.

EPS missed the consensus estimate of $-0.33 by $0.42.

You can read the 10-Q periodic report (0001493152-24-031150) directly on SEC EDGAR. The filing index links above go to sec.gov.